| Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy P Sarantis, E Koustas, A Papadimitropoulou, AG Papavassiliou, ... World journal of gastrointestinal oncology 12 (2), 173, 2020 | 336 | 2020 |
| Pancreatic cancer and cachexia—metabolic mechanisms and novel insights KA Poulia, P Sarantis, D Antoniadou, E Koustas, A Papadimitropoulou, ... Nutrients 12 (6), 1543, 2020 | 87 | 2020 |
| Gastrointestinal stromal tumors (GISTs): novel therapeutic strategies with immunotherapy and small molecules C Vallilas, P Sarantis, A Kyriazoglou, E Koustas, S Theocharis, ... International Journal of Molecular Sciences 22 (2), 493, 2021 | 57 | 2021 |
| Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer A Anestis, P Sarantis, S Theocharis, I Zoi, D Tryfonopoulos, ... Journal of cancer research and clinical oncology 145, 1221-1233, 2019 | 49 | 2019 |
| The interplay of autophagy and tumor microenvironment in colorectal cancer—ways of enhancing immunotherapy action E Koustas, P Sarantis, G Kyriakopoulou, AG Papavassiliou, ... Cancers 11 (4), 533, 2019 | 47 | 2019 |
| The resistance mechanisms of checkpoint inhibitors in solid tumors E Koustas, P Sarantis, AG Papavassiliou, MV Karamouzis Biomolecules 10 (5), 666, 2020 | 42 | 2020 |
| Autophagy-related proteins as a prognostic factor of patients with colorectal cancer E Koustas, P Sarantis, S Theoharis, AA Saetta, I Chatziandreou, ... American journal of clinical oncology 42 (10), 767-776, 2019 | 33 | 2019 |
| Histone deacetylase inhibitors in the treatment of hepatocellular carcinoma: Current evidence and future opportunities N Garmpis, C Damaskos, A Garmpi, VE Georgakopoulou, P Sarantis, ... Journal of Personalized Medicine 11 (3), 223, 2021 | 25 | 2021 |
| Pancreatic cancer prognosis, malnutrition risk, and quality of life: a cross-sectional study KA Poulia, D Antoniadou, P Sarantis, MV Karamouzis Nutrients 14 (3), 442, 2022 | 23 | 2022 |
| Pregnane X receptor (PXR) polymorphisms and cancer treatment A Skandalaki, P Sarantis, S Theocharis Biomolecules 11 (8), 1142, 2021 | 23 | 2021 |
| The role of the RANKL/RANK axis in the prevention and treatment of breast cancer with immune checkpoint inhibitors and anti-RANKL A Simatou, P Sarantis, E Koustas, AG Papavassiliou, MV Karamouzis International Journal of Molecular Sciences 21 (20), 7570, 2020 | 22 | 2020 |
| EPHA2, EPHA4, and EPHA7 expression in triple-negative breast cancer I Nikas, C Giaginis, K Petrouska, P Alexandrou, A Michail, P Sarantis, ... Diagnostics 12 (2), 366, 2022 | 20 | 2022 |
| Clinical significance of histone deacetylase (HDAC)-1,-2,-4 and-6 expression in salivary gland tumors D Pouloudi, M Manou, P Sarantis, N Tsoukalas, G Tsourouflis, E Dana, ... Diagnostics 11 (3), 517, 2021 | 20 | 2021 |
| HuR protein in hepatocellular carcinoma: implications in development, prognosis and treatment V Papatheofani, G Levidou, P Sarantis, E Koustas, MV Karamouzis, ... Biomedicines 9 (2), 119, 2021 | 20 | 2021 |
| Ventricular remodeling of single-chambered myh6−/− adult zebrafish hearts occurs via a hyperplastic response and is accompanied by elastin deposition in the … P Sarantis, C Gaitanaki, D Beis Cell and tissue research 378, 279-288, 2019 | 20 | 2019 |
| Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives E Koustas, EM Trifylli, P Sarantis, N Papadopoulos, E Karapedi, G Aloizos, ... International Journal of Molecular Sciences 23 (12), 6664, 2022 | 19 | 2022 |
| Inhibition of c‐MET increases the antitumour activity of PARP inhibitors in gastric cancer models E Koustas, MV Karamouzis, P Sarantis, D Schizas, AG Papavassiliou Journal of cellular and molecular medicine 24 (18), 10420-10431, 2020 | 18 | 2020 |
| Histone deacetylases and their inhibitors in colorectal cancer therapy: Current evidence and future considerations N Garmpis, C Damaskos, A Garmpi, A Nonni, VE Georgakopoulou, ... Current Medicinal Chemistry 29 (17), 2979-2994, 2022 | 17 | 2022 |
| Predictive biomarkers for immune-related endocrinopathies following immune checkpoint inhibitors treatment A Shalit, P Sarantis, E Koustas, EM Trifylli, D Matthaios, MV Karamouzis Cancers 15 (2), 375, 2023 | 16 | 2023 |
| A Zebrafish In Vivo Phenotypic Assay to Identify 3-Aminothiophene-2-Carboxylic Acid-Based Angiogenesis Inhibitors A Papakyriakou, P Kefalos, P Sarantis, C Tsiamantas, KP Xanthopoulos, ... ASSAY and Drug Development Technologies 12 (9-10), 527-535, 2014 | 16 | 2014 |
MICHALIS KARAMOUZISNational and Kapodistrian University of Athens在 med.uoa.gr 的电子邮件经过验证
